Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)

32.06
Delayed Data
As of 3:59pm ET
 -0.46 / -1.41%
Today’s Change
17.56
Today|||52-Week Range
44.46
+37.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.5B

Company Description

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Contact Information

Amphastar Pharmaceuticals, Inc.
11570 6th Street
Rancho Cucamonga California 91730
P:(909) 980-9484
Investor Relations:

Employees

Shareholders

Mutual fund holders42.43%
Individual stakeholders24.22%
Other institutional21.12%

Top Executives

Zi Ping LuoChairman, COO & Chief Scientist
Yong Feng ZhangPresident, Chief Executive & Scientific Officer
William J. PetersChief Financial Officer, Treasurer, Director & EVP
Jacob LiawatidewiSecretary, Director, EVP-Sales & Marketing
Rong ZhouExecutive Vice President-Production Center